BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3905594)

  • 21. The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma.
    Philip T; Pinkerton R; Hartmann O; Patte C; Philip I; Biron P; Favrot M
    Clin Haematol; 1986 Feb; 15(1):205-17. PubMed ID: 3516490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
    Wu GQ
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):47-51. PubMed ID: 7687533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
    De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
    Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myelotoxicity due to cancer chemotherapy with special reference to autologous bone marrow transplantation].
    Nakamura S
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1195-202. PubMed ID: 6381786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
    Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
    Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
    Blystad A; Kvalheim G; Torlakovic E; Holte H; Jacobsen E; Beiske K; Vâlerhaugen H; Lenschow E; Kvaloy S
    Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
    Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
    Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
    [No Abstract]   [Full Text] [Related]  

  • 30. Indication for bone-marrow harvesting and purging in Burkitt's Lymphoma: a three-year experience.
    Philip I; Philip T; Favrot MC; Biron P; Lenoir GM
    IARC Sci Publ; 1985; (60):441-5. PubMed ID: 3905595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM; Stong RC; Youle RJ; Vallera DA
    J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
    Gabarre J; Leblond V; Sutton L; Azar N; Jouan M; Boccaccio C; Gonzalez H; Charlotte F; Gentilini M; Binet JL
    Bone Marrow Transplant; 1996 Dec; 18(6):1195-7. PubMed ID: 8971396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term survival of two patients with Burkitt's lymphoma treated by surgical resection and intensive chemotherapy].
    Matsuoka T; Yoshimoto S; Sonobe H; Kiyoku Y; Yamasaki M; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1988 Nov; 29(11):2101-4. PubMed ID: 3236417
    [No Abstract]   [Full Text] [Related]  

  • 34. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
    Fujishima N; Fujishima M; Inomata M; Yamanaka Y; Saitoh K; Kameoka Y; Yoshioka T; Saitoh H; Takahashi N; Hirokawa M; Sawada K
    Rinsho Ketsueki; 2007 Apr; 48(4):326-31. PubMed ID: 17515125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
    Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.
    Li Y; Huang S; Wang X; Zhou D; Huang K; Guo H; Fang J; Chen C; Liu Q
    J Trop Pediatr; 2010 Oct; 56(5):337-41. PubMed ID: 20065046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burkitt's lymphoma-- what is new?
    Abinya ON
    East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
    Pappa VI; Wilkes S; Salam A; Young BD; Lister TA; Rohatiner AZ
    Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burkitt's lymphoma--a model for intensive chemotherapy.
    Ziegler JL; Deisseroth AB; Applebaum FR; Graw RG
    Semin Oncol; 1977 Sep; 4(3):317-23. PubMed ID: 335519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.